Literature DB >> 34008094

Elevated serum progesterone does not impact euploidy rates in PGT-A patients.

Maria Luisa Pardiñas1, Mar Nohales1, Elena Labarta1,2, José María De Los Santos1, Amparo Mercader1,2, José Remohí1,2, Ernesto Bosch1,2, Maria José De Los Santos3,4,5.   

Abstract

PURPOSE: Some women undergoing stimulated cycles have elevated serum progesterone (P) on the day of ovulation trigger, but its effect on embryo quality is unclear. We analyze embryo quality among patients with high and low serum P undergoing preimplantation genetic testing for aneuploidy (PGT-A).
METHODS: This retrospective study included 1597 patients divided into two groups by serum P values: < 1.5 ng/mL or ≥ 1.5 ng/mL. A gonadotrophin-releasing hormone (GnRH) antagonist protocol was established for each patient. Serum P levels were measured on the day of triggering. Propensity score matching and Poisson regression were done. Age, body mass index, and ovarian sensitivity index were also compared.
RESULTS: Elevated serum P was not significantly associated with euploid embryo rate or other embryo-quality variables evaluated in our study. Age was the only variable associated with euploidy rate (per MII oocyte, P < 0.001; per biopsied embryo, P = 0.008), embryo biopsy rate (P < 0.001), absolute number of euploid embryos (P = 0.008), and top-quality embryo rate (P = 0.008). Categorical variables decreased in value for every year of increased age in patients with high serum P.
CONCLUSIONS: Elevated serum P did not affect the number of euploid and good-quality embryos for transfer in GnRH antagonist intracytoplasmic sperm injection (ICSI) cycles. Contrary to the clear influence of premature P elevation on endometrial receptivity based on literature, our results may help to tip the balance towards the absence of a negative effect of P elevation on embryo competence. More studies are needed to fully understand the effect of P elevation on reproductive outcomes.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Blastocyst; Embryo quality; Euploidy; PGT-A; Progesterone

Mesh:

Substances:

Year:  2021        PMID: 34008094      PMCID: PMC8324650          DOI: 10.1007/s10815-021-02197-y

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  29 in total

1.  Premature progesterone elevation does not alter oocyte quality in in vitro fertilization.

Authors:  R Fanchin; C Righini; F Olivennes; D de Ziegler; J Selva; R Frydman
Journal:  Fertil Steril       Date:  1996-06       Impact factor: 7.329

2.  The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting.

Authors: 
Journal:  Hum Reprod       Date:  2011-04-18       Impact factor: 6.918

3.  Follicular progesterone concentrations and messenger RNA expression of MATER and OCT-4 in immature bovine oocytes as predictors of developmental competence.

Authors:  R Urrego; E Herrera-Puerta; N A Chavarria; O Camargo; C Wrenzycki; N Rodriguez-Osorio
Journal:  Theriogenology       Date:  2014-12-30       Impact factor: 2.740

4.  The significance of premature luteinization in an oocyte-donation programme.

Authors:  M A B Melo; M Meseguer; N Garrido; E Bosch; A Pellicer; J Remohí
Journal:  Hum Reprod       Date:  2006-04-28       Impact factor: 6.918

5.  Late follicular phase progesterone elevation during ovarian stimulation is not associated with decreased implantation of chromosomally screened embryos in thaw cycles.

Authors:  Carlos Hernandez-Nieto; Joseph A Lee; Tamar Alkon-Meadows; Martha Luna-Rojas; Tanmoy Mukherjee; Alan B Copperman; Benjamin Sandler
Journal:  Hum Reprod       Date:  2020-08-01       Impact factor: 6.918

6.  Freeze-all embryo strategy in poor ovarian responders undergoing ovarian stimulation for in vitro fertilization.

Authors:  Yamei Xue; Xiaomei Tong; Haiyan Zhu; Kun Li; Songying Zhang
Journal:  Gynecol Endocrinol       Date:  2018-02-21       Impact factor: 2.260

Review 7.  Premature progesterone elevation: targets and rescue strategies.

Authors:  Barbara Lawrenz; Elena Labarta; Human Fatemi; Ernesto Bosch
Journal:  Fertil Steril       Date:  2018-04       Impact factor: 7.329

8.  Elevated progesterone in GnRH agonist down regulated in vitro fertilisation (IVFICSI) cycles reduces live birth rates but not embryo quality.

Authors:  Robert Lahoud; Michele Kwik; John Ryan; Moamar Al-Jefout; Jane Foley; Peter Illingworth
Journal:  Arch Gynecol Obstet       Date:  2011-08-19       Impact factor: 2.344

9.  Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone.

Authors:  F Ubaldi; J Smitz; A Wisanto; H Joris; J Schiettecatte; M P Derde; E Borkham; A Van Steirteghem; P Devroey
Journal:  Hum Reprod       Date:  1995-12       Impact factor: 6.918

Review 10.  Freeze-all strategy in IVF/ICSI cycles: an update on clinical utility.

Authors:  Matheus Roque; Beatrice Nuto Nóbrega; Marcello Valle; Marcos Sampaio; Selmo Geber; Thor Haahr; Peter Humaidan; Sandro C Esteves
Journal:  Panminerva Med       Date:  2018-06-28       Impact factor: 5.197

View more
  1 in total

Review 1.  Towards an Improved Understanding of the Effects of Elevated Progesterone Levels on Human Endometrial Receptivity and Oocyte/Embryo Quality during Assisted Reproductive Technologies.

Authors:  Nischelle R Kalakota; Lea C George; Sara S Morelli; Nataki C Douglas; Andy V Babwah
Journal:  Cells       Date:  2022-04-21       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.